GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PYC Therapeutics Ltd (GREY:PLOGF) » Definitions » Research & Development

PYC Therapeutics (PYC Therapeutics) Research & Development : A$39.05 Mil (TTM As of Dec. 2023)


View and export this data going back to 2019. Start your Free Trial

What is PYC Therapeutics Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. PYC Therapeutics's Research & Development for the six months ended in Dec. 2023 was A$21.85 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 was A$39.05 Mil.


PYC Therapeutics Research & Development Historical Data

The historical data trend for PYC Therapeutics's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PYC Therapeutics Research & Development Chart

PYC Therapeutics Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 14.00 24.03 35.15

PYC Therapeutics Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.11 17.92 17.95 17.20 21.85

PYC Therapeutics Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$39.05 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PYC Therapeutics  (GREY:PLOGF) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


PYC Therapeutics Research & Development Related Terms

Thank you for viewing the detailed overview of PYC Therapeutics's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.


PYC Therapeutics (PYC Therapeutics) Business Description

Traded in Other Exchanges
Address
6 Verdun Street, Harry Perkins Institute of Medical Research, Nedlands, Perth, WA, AUS, 6009
PYC Therapeutics Ltd is an RNA therapeutics drug development company, leveraging a proprietary delivery platform to solve the challenges in RNA therapeutics - safe and effective delivery of the drug inside the cell. The company's principal business activity is of of drug development and progressing the company's drug pipeline through preclinical and clinical development. Geographically, it operates only in Australia.

PYC Therapeutics (PYC Therapeutics) Headlines

From GuruFocus